{"id":{"repo_id":"sdstate","oai_identifier":"oai:openprairie.sdstate.edu:etd-2152"},"canonical_url":"https://search.dev.ndltd.org/etd/sdstate/oai:openprairie.sdstate.edu:etd-2152","repository":{"repo_id":"sdstate","name":"South Dakota State University","base_url":"https://openprairie.sdstate.edu/do/oai/"},"display":{"title":"Development and Characterization of A Recombinant Orf Virus Vector Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus","abstract":"<p>Orf virus (ORFV), the type member of the genus <em>Parapoxvirus</em> of the family <em>Poxviridae</em>, causes orf or cutaneous pustular dermatitis in sheep and goats. ORFV is a ubiquitous virus capable of re-infecting its hosts multiple times over time. ORFV causes a non-systemic, self-limiting disease which is usually restricted to the skin surrounding the virus entry sites. ORFV has evolved several immunomodulatory proteins (IMPs) that evade and/or modulate host immune responses to infection and contribute to virus virulence and disease pathogenesis. Given biological properties and unique immunomodula tor y properties, ORFV has gained significant attention in recent years for its potential as a vaccine delivery vector for use in veterinary medicine. Here we explored the potential of ORFV as a vaccine delivery vector for use in swine. The spike (S) protein of porcine epidemic diarrhea virus (PEDV) was used as our model antigen and the immunogenicity and protective efficacy of a recombinant ORFV expressing the full length S protein of PEDV (ORFV-PEDV-S) was assessed in pigs. The ORFV-PEDV-S virus was generated by homologous recombination and the DNA sequences of PEDV S were inserted into the ORFV121 gene locus, an immunomodulatory protein (IMP) encoded by ORFV that contributes to the virus virulence. The resultant recombinant virus was characterized <em>in vitro</em> and its immunogenicity and protective efficacy evaluated <em>in vivo</em>. Results of our study show that intramuscular (IM) immunization of swine with the ORF-PEDV-S recombinant virus elicited robust humoral immune responses and protected animals from clinica l disease. Additionally, IM immunization with the ORFV-PEDV-S led to reduced virus shedding in feces. The results of this study provide important information on the feasibility of ORFV as a vaccine delivery vector for use in swine.</p>","abstract_html":"&lt;p&gt;Orf virus (ORFV), the type member of the genus &lt;em&gt;Parapoxvirus&lt;/em&gt; of the family &lt;em&gt;Poxviridae&lt;/em&gt;, causes orf or cutaneous pustular dermatitis in sheep and goats. ORFV is a ubiquitous virus capable of re-infecting its hosts multiple times over time. ORFV causes a non-systemic, self-limiting disease which is usually restricted to the skin surrounding the virus entry sites. ORFV has evolved several immunomodulatory proteins (IMPs) that evade and/or modulate host immune responses to infection and contribute to virus virulence and disease pathogenesis. Given biological properties and unique immunomodula tor y properties, ORFV has gained significant attention in recent years for its potential as a vaccine delivery vector for use in veterinary medicine. Here we explored the potential of ORFV as a vaccine delivery vector for use in swine. The spike (S) protein of porcine epidemic diarrhea virus (PEDV) was used as our model antigen and the immunogenicity and protective efficacy of a recombinant ORFV expressing the full length S protein of PEDV (ORFV-PEDV-S) was assessed in pigs. The ORFV-PEDV-S virus was generated by homologous recombination and the DNA sequences of PEDV S were inserted into the ORFV121 gene locus, an immunomodulatory protein (IMP) encoded by ORFV that contributes to the virus virulence. The resultant recombinant virus was characterized &lt;em&gt;in vitro&lt;/em&gt; and its immunogenicity and protective efficacy evaluated &lt;em&gt;in vivo&lt;/em&gt;. Results of our study show that intramuscular (IM) immunization of swine with the ORF-PEDV-S recombinant virus elicited robust humoral immune responses and protected animals from clinica l disease. Additionally, IM immunization with the ORFV-PEDV-S led to reduced virus shedding in feces. The results of this study provide important information on the feasibility of ORFV as a vaccine delivery vector for use in swine.&lt;/p&gt;","abstract_has_math":false,"creators":["Hain, Kyle"],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Thesis - Open Access","degree_discipline":"Veterinary and Biomedical Sciences","degree_department":null,"school":null,"contributors":["Diego G. Diel"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-01-01T08:00:00Z","date_published":"2016-01-01T08:00:00Z","updated_at":"2026-07-24T04:28:36Z","subjects":["Orf","parapoxvirus","PEDV","vaccine","vector","virus","Biology","Microbiology","Veterinary Microbiology and Immunobiology","Virology"],"languages":[],"rights":[],"rights_urls":["http://rightsstatements.org/vocab/InC/1.0/"],"identifier_entries":[]},"links":{"outbound_url":"https://openprairie.sdstate.edu/etd/1151","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Diego G. Diel"]},{"key":"dc:creator","label":"Author","values":["Hain, Kyle"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2017-03-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Veterinary and Biomedical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis - Open Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Orf","parapoxvirus","PEDV","vaccine","vector","virus","Biology","Microbiology","Veterinary Microbiology and Immunobiology","Virology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["http://rightsstatements.org/vocab/InC/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://openprairie.sdstate.edu/etd/1151"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Orf virus (ORFV), the type member of the genus <em>Parapoxvirus</em> of the family <em>Poxviridae</em>, causes orf or cutaneous pustular dermatitis in sheep and goats. ORFV is a ubiquitous virus capable of re-infecting its hosts multiple times over time. ORFV causes a non-systemic, self-limiting disease which is usually restricted to the skin surrounding the virus entry sites. ORFV has evolved several immunomodulatory proteins (IMPs) that evade and/or modulate host immune responses to infection and contribute to virus virulence and disease pathogenesis. Given biological properties and unique immunomodula tor y properties, ORFV has gained significant attention in recent years for its potential as a vaccine delivery vector for use in veterinary medicine. Here we explored the potential of ORFV as a vaccine delivery vector for use in swine. The spike (S) protein of porcine epidemic diarrhea virus (PEDV) was used as our model antigen and the immunogenicity and protective efficacy of a recombinant ORFV expressing the full length S protein of PEDV (ORFV-PEDV-S) was assessed in pigs. The ORFV-PEDV-S virus was generated by homologous recombination and the DNA sequences of PEDV S were inserted into the ORFV121 gene locus, an immunomodulatory protein (IMP) encoded by ORFV that contributes to the virus virulence. The resultant recombinant virus was characterized <em>in vitro</em> and its immunogenicity and protective efficacy evaluated <em>in vivo</em>. Results of our study show that intramuscular (IM) immunization of swine with the ORF-PEDV-S recombinant virus elicited robust humoral immune responses and protected animals from clinica l disease. Additionally, IM immunization with the ORFV-PEDV-S led to reduced virus shedding in feces. The results of this study provide important information on the feasibility of ORFV as a vaccine delivery vector for use in swine.</p>"]},{"key":"dc:title","label":"Title","values":["Development and Characterization of A Recombinant Orf Virus Vector Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus"]}]}],"canonical_facts":{"dc:contributor":["Diego G. Diel"],"dc:creator":["Hain, Kyle"],"dc:date.available":["2017-03-01T08:00:00Z"],"dc:description.abstract":["<p>Orf virus (ORFV), the type member of the genus <em>Parapoxvirus</em> of the family <em>Poxviridae</em>, causes orf or cutaneous pustular dermatitis in sheep and goats. ORFV is a ubiquitous virus capable of re-infecting its hosts multiple times over time. ORFV causes a non-systemic, self-limiting disease which is usually restricted to the skin surrounding the virus entry sites. ORFV has evolved several immunomodulatory proteins (IMPs) that evade and/or modulate host immune responses to infection and contribute to virus virulence and disease pathogenesis. Given biological properties and unique immunomodula tor y properties, ORFV has gained significant attention in recent years for its potential as a vaccine delivery vector for use in veterinary medicine. Here we explored the potential of ORFV as a vaccine delivery vector for use in swine. The spike (S) protein of porcine epidemic diarrhea virus (PEDV) was used as our model antigen and the immunogenicity and protective efficacy of a recombinant ORFV expressing the full length S protein of PEDV (ORFV-PEDV-S) was assessed in pigs. The ORFV-PEDV-S virus was generated by homologous recombination and the DNA sequences of PEDV S were inserted into the ORFV121 gene locus, an immunomodulatory protein (IMP) encoded by ORFV that contributes to the virus virulence. The resultant recombinant virus was characterized <em>in vitro</em> and its immunogenicity and protective efficacy evaluated <em>in vivo</em>. Results of our study show that intramuscular (IM) immunization of swine with the ORF-PEDV-S recombinant virus elicited robust humoral immune responses and protected animals from clinica l disease. Additionally, IM immunization with the ORFV-PEDV-S led to reduced virus shedding in feces. The results of this study provide important information on the feasibility of ORFV as a vaccine delivery vector for use in swine.</p>"],"dc:identifier":["https://openprairie.sdstate.edu/etd/1151"],"dc:rights":["http://rightsstatements.org/vocab/InC/1.0/"],"dc:subject":["Orf","parapoxvirus","PEDV","vaccine","vector","virus","Biology","Microbiology","Veterinary Microbiology and Immunobiology","Virology"],"dc:title":["Development and Characterization of A Recombinant Orf Virus Vector Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus"],"thesis:degree_discipline":["Veterinary and Biomedical Sciences"],"thesis:degree_level":["Thesis - Open Access"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-07-24T04:28:36Z"}